Attached files

file filename
8-K - FORM 8-K - VANGUARD HEALTH SYSTEMS INCc11955e8vk.htm
EX-99.2 - EXHIBIT 99.2 - VANGUARD HEALTH SYSTEMS INCc11955exv99w2.htm
EX-99.1 - EXHIBIT 99.1 - VANGUARD HEALTH SYSTEMS INCc11955exv99w1.htm
EXHIBIT 99.3
VANGUARD HEALTH SYSTEMS, INC.
Calculation of Certain Financial Covenants under Senior Secured Credit Agreement
December 31, 2010
         
    Trailing  
    twelve months ended  
($ presented in millions)   December 31,  
Interest Coverage Ratio:   2010  
Adjusted EBITDA(1)
  $ 337.5  
Add: Equity method cash distributions received
    0.8  
Less: Non-controlling interest distributions paid
    (3.0 )
Add: Franchise tax expense
    0.2  
Add: Gross interest income recognized
    1.3  
Add: Capitalized interest recorded
    3.3  
Add: Pro forma adjustments for fiscal 2011 acquisitions
    162.3  
 
     
Consolidated EBITDA, as defined in senior secured credit agreement
  $ 502.4 A
 
       
Net interest
  $ 130.6  
Add: Capitalized interest recorded
    3.3  
Less: Non-cash accretion of senior discount and senior unsecured notes
    (1.8 )
Less: Non-cash amortization of financing costs
    (4.8 )
Less: Interest related to specified construction projects
    (3.1 )
Add: Pro forma adjustments for debt incurred to finance fiscal 2011 acquisitions
    9.7  
 
     
Consolidated cash interest expense, as defined in senior secured credit agreement
  $ 133.9 B
 
       
Interest coverage ratio (A/B)
    3.75 x
 
     
 
       
Minimum interest coverage ratio required as of December 31, 2010
    2.00 x
 
     
         
    As of  
    December 31,  
Leverage Ratio:   2010  
Term debt and senior notes outstanding
  $ 1,967.5  
Less: Cash and cash equivalents
    (58.3 )
Less: Restricted cash
    (3.0 )
Less: Debt incurred to fund specified construction projects
    (73.5 )
 
     
Consolidated debt, as defined in senior secured credit agreement
  $ 1,832.7 C
 
       
Consolidated EBITDA, as defined in senior secured credit agreement
  $ 502.4 A
 
       
Leverage ratio (C/A)
    3.65 x
 
     
 
       
Maximum leverage ratio allowed as of December 31, 2010
    6.25 x
 
     

 


 

VANGUARD HEALTH SYSTEMS, INC.
Calculation of Certain Financial Covenants under Senior Secured Credit Agreement
December 31, 2010
(continued)
 
     
(1)   Adjusted EBITDA is defined as income before interest expense (net of interest income), income taxes, depreciation and amortization, non-controlling interests, gain or loss on disposal of assets, equity method income, stock compensation, monitoring fees and expenses, realized and unrealized gains or losses on investments, debt extinguishment costs, acquisition related expenses, impairment losses, pension expense and discontinued operations, net of taxes. Adjusted EBITDA is not intended as a substitute for net income (loss) attributable to Vanguard Health Systems, Inc. stockholders, operating cash flows or other cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Due to varying methods of calculation, Adjusted EBITDA as presented may not be comparable to similarly titled measures of other companies. The following table provides a reconciliation of Adjusted EBITDA to net income (loss) attributable to Vanguard Health Systems, Inc. stockholders during the trailing twelve months ended December 31, 2010 (in millions).
                                 
            Add:     Less:     Trailing  
    Six months ended     Year ended     Six months ended     twelve months ended  
    December 31,     June 30,     December 31,     December 31,  
    2010     2010     2009     2010  
Net loss attributable to Vanguard Health Systems, Inc. stockholders
  $ (3.8 )   $ (49.2 )   $ (19.2 )   $ (33.8 )
Interest, net
    69.9       115.5       54.8       130.6  
Income tax expense (benefit)
    7.3       (13.8 )     (1.7 )     (4.8 )
Depreciation and amortization
    75.8       139.6       67.6       147.8  
Non-controlling interests
    1.8       2.9       1.7       3.0  
Loss on disposal of assets
    0.1       1.8       0.4       1.5  
Equity method income
    (0.6 )     (0.9 )     (0.5 )     (1.0 )
Stock compensation
    2.9       4.2       2.9       4.2  
Monitoring fees and expenses
    2.5       5.1       2.7       4.9  
Realized loss on investments
    0.1                   0.1  
Debt extinguishment costs
          73.5             73.5  
Acquisition related expenses
    5.0       3.1             8.1  
Impairment loss
    0.9       43.1       43.1       0.9  
Discontinued operations, net of taxes
    2.2       1.7       1.4       2.5  
 
                       
Adjusted EBITDA
  $ 164.1     $ 326.6     $ 153.2     $ 337.5